David Lillicrap, MD, discusses AAV gene therapy in a canine hemophilia model

(3:30)

An Overview of Gene Therapy with Professor David Lillicrap

(35:58)

#VWDTalk How does understanding genetics help us manage Von Willebrand Disease? |Dr. David Lillicrap

(5:4)

One size does NOT fit all with Professor David Lillicrap, Dr Víctor Jimenez-Yuste and patient

(23:3)

Co-Editor-in-Chief David Lillicrap Discusses the Role of JTH during the COVID-19 Pandemic

(7:50)

What is gene therapy for hemophilia?

(15:10)

🧬 David Li - Meliora Therapeutics - Part 2

(30:51)

Deepmind AlphaZero - Mastering Games Without Human Knowledge

(42:29)

My Strategy To Consume Information Effectively

(18:23)

Jason Wei: Scaling Paradigms for Large Language Models

(40:10)

Which Country Has the Best \u0026 Worst Life Expectancy? Why? - TLDR News

(9:18)

Hemophilia Webinar

(1:26:26)

Advancements in Treatment for Hemophilia

(58:50)

Hemophilia | Pediatrics | Target NEET PG 2021 | Dr. Shilpa Dinesh

(1:6:45)

DRL Lecture 6: Actor-Critic

(34:16)

La famille, l'épargne et Dieu (décembre 2024)

(40:46)

David Lillicrap: Can We Cure Haemophilia? at SACC 2017

(47:24)

Getting to Know Gene Therapy Terminology and Concepts

(19:28)

#RendezVous2017 - Session 1 - A BRAVE NEW WORLD IN COAGULATION THERAPIES

(2:26)

CHS Rendez-vous 2017 / SESSION 1 - A BRAVE NEW WORLD IN COAGULATION THERAPIES

(21:57)

What are the clinical trial results in hemophilia gene therapy?

(13:54)

Mechanisms of Tolerance: Immune tolerance induction

(29:22)

CHS Rendez-vous 2023 / SESSION 4: GENE THERAPY: MANAGING EXPECTATIONS

(16:12)

New Therapies for Hemophilia: Balancing Caution with Excitement

(31:)

New Developments in Treatment for Bleeding Disorders – Personalized Prophylaxis

(8:11)

CHS Rendez-vous 2023 / SESSION 4: GENE THERAPY: MANAGING EXPECTATIONS

(27:8)

The evolving treatment landscape of hemophilia - Professor Johnny Mahlangu

(17:47)

Meet the New JTH Editors and Learn About Submission Changes

(5:42)

Hemophilia Gene Therapy-Readying for Clinical Care

(6:4)